-
1دورية أكاديمية
المؤلفون: Liao, Pei-Ya, Ou, Wei-Fan, Su, Kang-Yi, Sun, Ming-Hsi, Huang, Chih-Mei, Chen, Kun-Chieh, Hsu, Kuo-Hsuan, Yu, Sung-Liang, Huang, Yen-Hsiang, Tseng, Jeng-Sen, Yang, Tsung-Ying, Chang, Gee-Chen
المصدر: Cancers; Jun2022, Vol. 14 Issue 12, p2824-N.PAG, 11p
مصطلحات موضوعية: ADENOCARCINOMA, LUNG cancer, MENINGEAL cancer, GENETIC mutation, CONFIDENCE intervals, EPIDERMAL growth factor receptors, MULTIVARIATE analysis, METASTASIS, CANCER patients, DESCRIPTIVE statistics, CEREBROSPINAL fluid, TUMOR markers, MEDICAL needs assessment
-
2دورية أكاديمية
المؤلفون: Hsu, Kuo-Hsuan, Tseng, Jeng-Sen, Yang, Tsung-Ying, Chen, Kun-Chieh, Su, Kang-Yi, Yu, Sung-Liang, Chen, Jeremy J. W., Huang, Yen-Hsiang, Chang, Gee-Chen
المصدر: Scientific Reports; 6/13/2022, Vol. 12 Issue 1, p1-10, 10p
مصطلحات موضوعية: NON-small-cell lung carcinoma, PROGRAMMED cell death 1 receptors, PROGRAMMED death-ligand 1, EPIDERMAL growth factor receptors, CANCER patients, TREATMENT effectiveness
-
3دورية أكاديمية
المؤلفون: Huang, Yen-Hsiang, Tseng, Jeng-Sen, Hsu, Kuo-Hsuan, Chen, Kun-Chieh, Su, Kang-Yi, Yu, Sung-Liang, Chen, Jeremy J. W., Yang, Tsung-Ying, Chang, Gee-Chen
المصدر: Scientific Reports; 6/8/2021, Vol. 11 Issue 1, p1-10, 10p
مصطلحات موضوعية: EPIDERMAL growth factor receptors, OSIMERTINIB, NON-small-cell lung carcinoma, DRUG efficacy, PROGRESSION-free survival
-
4دورية أكاديمية
المؤلفون: Tseng, Jeng-Sen, Hsu, Kuo-Hsuan, Zheng, Zhe-Rong, Yang, Tsung-Ying, Chen, Kun-Chieh, Huang, Yen-Hsiang, Su, Kang-Yi, Yu, Sung-Liang, Chang, Gee-Chen
المصدر: Oncology; 2021, Vol. 99 Issue 1, p32-40, 9p
مصطلحات موضوعية: THERAPEUTIC use of antineoplastic agents, LUNG cancer prognosis, ADENOCARCINOMA, CANCER patients, COMPARATIVE studies, CONFIDENCE intervals, LUNG cancer, MEDICAL records, GENETIC mutation, SURVIVAL, PROTEIN-tyrosine kinase inhibitors, TREATMENT effectiveness, RETROSPECTIVE studies, EPIDERMAL growth factor receptors, DESCRIPTIVE statistics, ACQUISITION of data methodology
-
5دورية أكاديمية
المؤلفون: Su, Kang-Yi1,2,3,4, Tseng, Jeng-Sen5,6, Liao, Keng-Mao4, Yang, Tsung-Ying5,6, Chen, Kun-Chieh5, Hsu, Kuo-Hsuan5, Yang, Pan-Chyr7, Yu, Sung-Liang1,2,3,8,9,10, Chang, Gee-Chen5,6,11
المصدر: PLoS ONE. 11/16/2018, Vol. 13 Issue 11, p1-15. 15p.
مصطلحات موضوعية: *LUNG cancer & genetics, *ADENOCARCINOMA, *GENETIC mutation, *EPIDERMAL growth factor receptors, *BIOLOGICAL monitoring, *PEPTIDE nucleic acids
-
6دورية أكاديمية
المؤلفون: Lin, Chia-Chi, Shih, Jin-Yuan, Yu, Chong-Jen, Ho, Chao-Chi, Liao, Wei-Yu, Lee, Jih-Hsing, Tsai, Tzu-Hsiu, Su, Kang-Yi, Hsieh, Min-Shu, Chang, Yih-Leong, Bai, Ya-Ying, Huang, Derek De-Rui, Thress, Kenneth S, Yang, James Chih-Hsin
المصدر: Lancet Respiratory Medicine; Feb2018, Vol. 6 Issue 2, p107-116, 10p
مصطلحات موضوعية: CANCER treatment, NON-small-cell lung carcinoma, EPIDERMAL growth factor receptors, CLINICAL trials, THERAPEUTICS
-
7دورية أكاديمية
المؤلفون: Pan, Szu‐Hua1,2,3, Su, Kang‐Yi4,5,6, Spiessens, Bart7, Kusuma, Nicole7, Delahaye, Nicolas F7, Gruselle, Olivier7, Myo, Aung7, Creus, An7, Louahed, Jamila7, Chang, Gee‐Cheng8,9,10, Yu, Sung‐Liang4,5,6 slyu@ntu.edu.tw, Yang, Pan‐Chyr4,11,12
المصدر: Asia Pacific Journal of Clinical Oncology. Oct2017, Vol. 13 Issue 5, pe212-e223. 12p.
مصطلحات موضوعية: *TUMOR antigen genetics, *GENE expression, *EPIDERMAL growth factor receptors, *MELANOMA, *NON-small-cell lung carcinoma, *PATIENTS, *GENETICS
-
8دورية أكاديمية
المؤلفون: Huang, Yen-Hsiang, Tseng, Jeng-Sen, Hsu, Kuo-Hsuan, Chen, Kun-Chieh, Su, Kang-Yi, Yu, Sung-Liang, Chen, Jeremy J. W., Yang, Tsung-Ying, Chang, Gee-Chen
المصدر: Scientific Reports; 8/30/2021, Vol. 11 Issue 1, p1-2, 2p
مصطلحات موضوعية: EPIDERMAL growth factor receptors, OSIMERTINIB
-
9دورية أكاديمية
المؤلفون: Tseng, Jeng-Sen, Wang, Chih-Liang, Huang, Ming-Shyan, Chen, Chung-Yu, Chang, Cheng-Yu, Yang, Tsung-Ying, Tsai, Chi-Ren, Chen, Kun-Chieh, Hsu, Kuo-Hsuan, Tsai, Meen-Hsin, Yu, Sung-Liang, Su, Kang-Yi, Wu, Chih-Wei, Yang, Cheng-Ta, Chen, Yuh-Min, Chang, Gee-Chen
المصدر: PLoS ONE; Sep2014, Vol. 9 Issue 9, p1-8, 8p
مصطلحات موضوعية: LUNG cancer patients, EPIDERMAL growth factor receptors, GENETIC mutation, ERLOTINIB, PHARMACODYNAMICS
-
10دورية أكاديمية
المؤلفون: Hsu, Kuo-Hsuan1,2 vghryan@gmail.com, Huang, Yen-Hsiang1,3 waynehuang0622@gmail.com, Tseng, Jeng-Sen3,4 tzeng64@gmail.com, Chen, Kun-Chieh3 ckjohn@mail2000.com.tw, Ku, Wen-Hui5 whku0322@gmail.com, Su, Kang-Yi6,7 jwchen@dragon.nchu.edu.tw, Chen, Jeremy J.W.2 jwchen@dragon.nchu.edu.tw, Chen, Huei-Wen8 shwchen@ntu.edu.tw, Yu, Sung-Liang6,7,9,10,11 slyu@ntu.edu.tw, Yang, Tsung-Ying1,3,4 jonyin@gmail.com, Chang, Gee-Chen1,3,4,12 august@vghtc.gov.tw
المصدر: Lung Cancer (01695002). Jan2019, Vol. 127, p37-43. 7p.
مصطلحات موضوعية: *EPIDERMAL growth factor receptors, *LUNGS, *KINASE inhibitors, *PREVENTIVE medicine, *PROGRESSION-free survival